Skip to main content

Advertisement

SpringerLink
Log in

A review of malignant meningiomas: diagnosis, characteristics, and treatment

  • Invited Review
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Anaplastic or malignant meningiomas (WHO Grade III) represent the most rare but aggressive subtype, accounting for 1–3% of all intracranial meningiomas. Due in large part to their scarcity, malignant meningiomas have been understudied and therefore represent an area where significant clinical advances may be made. To this point, our understanding of the genetic and histologic attributes of these lesions has grown, though the management and treatment of these aggressive tumors is less well elucidated and thus has room for further study. In this review, we describe the current understanding of malignant meningiomas in terms of their genetic alterations and unique histologic markers. Using this as a foundation, we will then discuss the current therapeutic strategies for managing these lesions and the future direction that such interventions may take.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) (2007) WHO classification of tumours of the central nervous system, 4th edn. IARC Press, Lyon

    Google Scholar 

  2. Cushing HW, Eisenhardt LC (1938) Serial enumeration of meningiomas. In: Thomas CC (ed) Meningiomas their classification regional behavior, life history and surgical end results. Springfield, Thomas CC, pp 56–73

    Google Scholar 

  3. Perry A, Louis DN, Scheithauer BW, Budka H, Von Deimling A (2007) Meningiomas. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumours of the central nervous system, 4th edn. IARC Press, Lyon, pp 164–172

    Google Scholar 

  4. Durand A, Labrousse F, Jouvet A, Bauchet L, Kalamardies M, Menei P, Deruty R, Moreau JJ, Fevre-Montange M, Guyotat J (2009) WHO grade II and III meningiomas: a study of prognostic factors. J Neurooncol 95:367–375

    Article  PubMed  Google Scholar 

  5. Pasquier D, Bijmolt S, Veninga T, Rezvoy N, Villa S, Krengli M, Weber DC, Baumert BG, Canyilmaz E, Yalman D, Szutowicz E, Tzuk-Shina T, Mirimanoff RO (2008) Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients a multicenter, retrospective study of the rare cancer network. Int J Radiat Oncol Biol Phys 71:1388–1393

    PubMed  Google Scholar 

  6. Zulch K (1979) Histological typing of central nervous system tumours. World Health Organization, Geneva, pp 53–55

    Google Scholar 

  7. Commins D, Atkinson RD, Burnett M (2007) Review of meningioma histopathology. Neurosurg Focus 23(4):1–9 E3

    Article  Google Scholar 

  8. Gladin CR, Salsano E, Menghi F, Grisoli M, Ghielmetti F, Milanesi I, Pollo B, Brock S, Cusin A, Finocchiaro G, Bruzzone MG (2007) Loss of heterozygosity studies in extracranial metastatic meningiomas. J Neurooncol 85(1):81–85

    Article  PubMed  Google Scholar 

  9. Rajaram V, Brat D, Perry A (2004) Anaplastic meningioma versus meningeal hemangiopericytoma: immunohistochemical and genetic markers. Hum Pathol 35(11):1413–1418

    Article  CAS  PubMed  Google Scholar 

  10. Perry A, Scheithauer BW, Stafford SL, Lohse CM, Wollan PC (1999) “Malignancy” in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 85:2046–2056

    CAS  PubMed  Google Scholar 

  11. Jaaskelainen J, Haltia M, Servo A (1986) Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. Surg Neurol 25(3):233–242

    Article  CAS  PubMed  Google Scholar 

  12. Gianni C, Rushing EJ, Hainfellner JA (2007) Hemangiopericytoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumours of the central nervous system, 4th edn. IARC Press, Lyon, pp 178–180

    Google Scholar 

  13. Ribalta T, McCutcheon IE, Aldape K, Bruner J, Fuller GN (2004) The mitosis-specific antibody anti-phosphohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria. Am J Surg Pathol 28(11):1532–1536

    Article  PubMed  Google Scholar 

  14. Bruna J, Brell M, Ferrer I, Gimenez-Bonafe P, Tortosa A (2007) Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma. Neuropathology 27:114–120

    Article  PubMed  Google Scholar 

  15. Ozen O, Demirhan B, Altinors N (2005) Correlation between histological grade and MIB-1 and p53 immunoreactivity in meningiomas. Clin Neuropathol 24(5):219–224

    CAS  PubMed  Google Scholar 

  16. Modha A, Gutin PH (2005) Diagnosis and treatment of atypical and anaplastic meningiomas: a review. Neurosurgery 57(3):538–550

    Article  PubMed  Google Scholar 

  17. Wolfsberger S, Doostkam S, Boecher-Schwarz HG, Roessler K, van Trotsenburg M, Hainfellner JA, Knosp E (2004) Progesterone-receptor index in meningiomas: correlation with clinico-pathological parameters and review of the literature. Neurosurg Rev 27(4):238–245

    Article  PubMed  Google Scholar 

  18. Hsu C, Pai C, Kao H, Hsueh C, Hsu W, Lo C (2010) Do aggressive imaging features correlate with advanced histopathological grade in meningiomas? J Clin Neurosci 17(5):584–587

    Article  PubMed  Google Scholar 

  19. Hakyemez B, Yildirim N, Gokalp G, Erdogan C, Parlak M (2006) The contribution of diffusion-weighted MR imaging to distinguishing typical from atypical meningiomas. Neuroradiology 48:513–520

    Article  PubMed  Google Scholar 

  20. Nagar VA, Ye JR, Ng WH, Chan YH, Hui F, Lee CK, Lim CCT (2008) Diffusion-weighted MR imaging: diagnosing atypical or malignant meningiomas and detecting tumor dedifferentiation. AJNR Am J Neuroradiol 29(6):1147–1152

    Article  CAS  PubMed  Google Scholar 

  21. Shiino A, Nakasu S, Matsuda M, Handa J, Morikawa S, Inubushi T (1999) Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy. J Neurosurg 91:928–934

    Article  Google Scholar 

  22. Demir MK, Iplikcioglu AC, Dincer A, Arslan M, Sav A (2006) Single voxel proton MR spectroscopy findings of typical and atypical intracranial meningiomas. Eur J Radiol 60(1):48–55

    Article  PubMed  Google Scholar 

  23. Yue Q, Isobe T, Shibata Y, Anno I, Kawamura H, Yamamoto Y, Takano S, Matsumura A (2008) New observations concerning the interpretation of magnetic resonance spectroscopy of meningioma. Eur Radiol 18:2901–2911

    Article  PubMed  Google Scholar 

  24. Toh C-H, Castillo M, Wong AM-C, Wei K-C, Wong H-F, Ng S-H, Wan Y-L (2008) Differentiation between classic and atypical meningiomas with use of diffusion tensor imaging. AJNR Am J Neuroradiol 29(9):1630–1635

    Article  PubMed  Google Scholar 

  25. Jolapara M, Kesavadas C, Radhakrishnan VV, Thomas B, Gupta AK, Bodhey N, Patro S, Saini J, George U, Sarma PS (2010) Role of diffusion tensor imaging in differentiating subtypes of meningiomas. J Neuroradiol (Epub ahead of print)

  26. Riemenschneider M, Perry A, Reifenberger G (2006) Histological classification and molecular genetics of meningiomas. Lancet Neurol 5:1045–1054

    Article  CAS  PubMed  Google Scholar 

  27. Leone PE, Bello MJ, de Campos JM et al (1999) NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas. Oncogene 18:2231–2239

    Article  CAS  PubMed  Google Scholar 

  28. Ozaki S, Nishizaki T, Ito H, Sasaki K (1999) Comparative genomic hybridization analysis of genetic alterations associated with malignant progression of meningioma. J Neurooncol 41:167–174

    Article  CAS  PubMed  Google Scholar 

  29. Bostrom J, Meyer-Puttlitz B, Wolter M et al (2001) Alterations of the tumor suppressor genes CDKN2A (P16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas. Am J Pathol 159:661–669

    CAS  PubMed  Google Scholar 

  30. Perry A, Banerjee R, Lohse CM, Kleinschmidt-DeMasters BK, Scheithauer BW (2002) A role for chromosome 9p21 deletions in the malignant progression of meningiomas and the prognosis of anaplastic meningiomas. Brain Pathol 12:183–190

    CAS  PubMed  Google Scholar 

  31. Lusis EA, Watson MA, Chrcoine MR et al (2005) Integrative genomic analysis identifies NDGR2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningiomas. Cancer Res 65:7121–7126

    Article  CAS  PubMed  Google Scholar 

  32. Bates S, Phillips AC, Clark PA et al (1998) p14ARF links the tumour suppressors RB and p53. Nature 395:124–125

    Article  CAS  PubMed  Google Scholar 

  33. Milosevic MF, Frost PJ, Laperriere NJ, Wong CS, Simpson WJ (1996) Radiotherapy for atypical or malignant intracranial meningioma. Int J Radat Oncol Biol Phys 34(4):817–822

    Article  CAS  Google Scholar 

  34. Dziuk TW, Woo SY, Butler EB, Grossman RG, Goodman C, Harper R, Narayan R, Thornby J, Dennis WS, Hu HL, Carpenter LS, Chiu JK, Munkarah M (1993) Malignant meningioma: an indication for radiotherapy. Int J Radiol Oncol Biol Phys 27(Suppl):264

    Article  Google Scholar 

  35. Sughrue ME, Sanai N, Shangari G, Parsa AT, Berger MS, McDermott MW (2010) Outcome and survival following primary and repeat surgery for World Health Organization Grade III meningiomas. J Neurosurg 113(2):202–209

    Article  PubMed  Google Scholar 

  36. Rosenberg LA, Prayson RA, Lee J, Reddy C, Chao ST, Barnett GH, Vogelbaum MA, Suh JH (2009) Long-term experience with World Health Organization Grade III (malignant) meningiomas at a single institution. Int J Radiat Oncol Biol Phys 74(2):427–432

    PubMed  Google Scholar 

  37. Boskos C, Feuvret L, Noel G, Habrand J-L, Pommier P, Alapetite C, Mammar H, Ferrand R, Boisserie G, Mazeron J-J (2009) Combined proton and photon conformal radiotherapy for intracranial atypical and malignant meningioma. Int J Radiat Oncol Biol Phys 75(2):399–406

    PubMed  Google Scholar 

  38. Dziuk TW, Woo S, Butler EB, Thornby J, Grossman R, Dennis WS, Lu H, Carpenter LS, Chiu JK (1998) Malignant meningioma: an indication for initial aggressive surgery and adjuvant radiotherapy. J Neurooncol 37(2):177–188

    Article  CAS  PubMed  Google Scholar 

  39. Hug EB, DeVries A, Thornton AF, Munzenrider JE, Pardo FS, Hedley-Whyte ET, Bussiere MR, Ojemann R (2000) Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy. J Neurooncol 48:151–160

    Article  CAS  PubMed  Google Scholar 

  40. Mattozo CA, De Salles AA, Klement IA, Gorgulho A, McArthur D, Ford J, Agazaryan N, Kelly DF, Selch MT (2007) Stereotactic radiation treatment for recurrent nonbenign meningiomas. J Neurosurg 106:846–854

    Article  PubMed  Google Scholar 

  41. Schrell UM, Rittig MG, Anders M, Koch UH, Marschalek R, Kiesewetter F et al (1997) Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea. J Neurosurg 86:840–844

    Article  CAS  PubMed  Google Scholar 

  42. Norden AD, Drappatz J, Wen PY (2007) Targeted drug therapy for meningiomas. Neurosurg Focus 23(4):E12

    Article  PubMed  Google Scholar 

  43. Chamberlain MC, Glantz MJ, Fadul CE (2007) Recurrent meningioma: salvage therapy with long-acting somatostatin analogue. Neurology 69:969–973

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurological Surgery, Columbia University Medical Center, 710 W. 168th St, New York, NY, 10032, USA

    Simon Hanft, Peter Canoll & Jeffrey N. Bruce

Authors
  1. Simon Hanft
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter Canoll
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jeffrey N. Bruce
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Simon Hanft.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hanft, S., Canoll, P. & Bruce, J.N. A review of malignant meningiomas: diagnosis, characteristics, and treatment. J Neurooncol 99, 433–443 (2010). https://doi.org/10.1007/s11060-010-0348-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-010-0348-9

Keywords

Search

Navigation